Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial

BACKGROUND: The Orsiro Hybrid sirolimus-eluting stent is a newly developed third-generation drug-eluting stent, featuring a unique dual-polymer mix. An active bioabsorbable polymer delivers the anti-proliferative drug, sirolimus, via controlled release, while a passive biocompatible polymeric coatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joo Myung, Park, Sang-Don, Lim, Sang Yup, Doh, Joon-Hyung, Cho, Jin Man, Kim, Ki-Seok, Bae, Jang-Whan, Chung, Woo-Young, Youn, Tae-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842627/
https://www.ncbi.nlm.nih.gov/pubmed/24257456
http://dx.doi.org/10.1186/1745-6215-14-398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842627/
https://www.ncbi.nlm.nih.gov/pubmed/24257456
http://dx.doi.org/10.1186/1745-6215-14-398

Ejemplares similares